Cargando…

Next generation viscoelasticity assays in cardiothoracic surgery: Feasibility of the TEG6s system

BACKGROUND: Viscoelastic near-patient assays of global hemostasis have been found useful and cost-effective in perioperative settings. Shortcomings of current systems include substantial laboratory intensity, user-dependent reproducibility, relatively large sample volumes, sensitivity to ambient vib...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdoes, Gabor, Schloer, Hannes, Eberle, Balthasar, Nagler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301661/
https://www.ncbi.nlm.nih.gov/pubmed/30571781
http://dx.doi.org/10.1371/journal.pone.0209360
_version_ 1783381837003882496
author Erdoes, Gabor
Schloer, Hannes
Eberle, Balthasar
Nagler, Michael
author_facet Erdoes, Gabor
Schloer, Hannes
Eberle, Balthasar
Nagler, Michael
author_sort Erdoes, Gabor
collection PubMed
description BACKGROUND: Viscoelastic near-patient assays of global hemostasis have been found useful and cost-effective in perioperative settings. Shortcomings of current systems include substantial laboratory intensity, user-dependent reproducibility, relatively large sample volumes, sensitivity to ambient vibration and limited comparability between techniques and devices. The aim of this study was to assess feasibility of a new, resonance-based viscoelastic whole blood methodology (TEG6s) in cardiac surgery with cardiopulmonary bypass (CPB) and to compare the parameters this system produces with the ROTEM delta system and standard coagulation tests. METHODS: In a prospective evaluation study, twenty-three consecutive cardiac surgery patients underwent hemostasis management according to current guidelines, using the ROTEM delta system and standard coagulation tests. Blood samples were collected prior to CPB before anesthetic induction (pre-CPB), during CPB on rewarming (CPB), and 10 minutes after heparin reversal with protamine (post-CPB). ROTEM and standard coagulation test results were compared with TEG6s parameters, which were concurrently determined using its multi-channel microfluidic cartridge system. RESULTS: TEG6s provided quantifiable results pre-CPB and post-CPB, but only R (clotting time) of CKH (kaolin with heparinase) was measurable during CPB (full heparinization). Spearman’s correlation coefficient (r(s)) was 0.78 for fibrinogen levels and MA CFF (functional fibrinogen). Correlation of several TEG6s parameters was good (0.77 to 0.91) with MCF FIBTEM, and poor (<0.56) with prothrombin time and activated partial thromboplastin time (<0.44). R(s) with platelet count was moderate (0.70, MA CK; 0.73, MA CRT). Accuracy of MA CFF for detection of fibrinogen deficiency < 1.5 g/L was high (ROC-AUC 0.93). CONCLUSIONS: The TEG6s system, which is based on resonance viscoelastic methodology, appears to be feasible for POC hemostasis assessment in cardiac surgery. Its correlations with standard coagulation parameters are quite similar to those of ROTEM and there is good diagnostic accuracy for fibrinogen levels lower than 1.5 g/L. During full heparinization, TEG6s testing is limited to R measurement. Larger studies are needed to assess superiority over other POC systems.
format Online
Article
Text
id pubmed-6301661
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63016612019-01-08 Next generation viscoelasticity assays in cardiothoracic surgery: Feasibility of the TEG6s system Erdoes, Gabor Schloer, Hannes Eberle, Balthasar Nagler, Michael PLoS One Research Article BACKGROUND: Viscoelastic near-patient assays of global hemostasis have been found useful and cost-effective in perioperative settings. Shortcomings of current systems include substantial laboratory intensity, user-dependent reproducibility, relatively large sample volumes, sensitivity to ambient vibration and limited comparability between techniques and devices. The aim of this study was to assess feasibility of a new, resonance-based viscoelastic whole blood methodology (TEG6s) in cardiac surgery with cardiopulmonary bypass (CPB) and to compare the parameters this system produces with the ROTEM delta system and standard coagulation tests. METHODS: In a prospective evaluation study, twenty-three consecutive cardiac surgery patients underwent hemostasis management according to current guidelines, using the ROTEM delta system and standard coagulation tests. Blood samples were collected prior to CPB before anesthetic induction (pre-CPB), during CPB on rewarming (CPB), and 10 minutes after heparin reversal with protamine (post-CPB). ROTEM and standard coagulation test results were compared with TEG6s parameters, which were concurrently determined using its multi-channel microfluidic cartridge system. RESULTS: TEG6s provided quantifiable results pre-CPB and post-CPB, but only R (clotting time) of CKH (kaolin with heparinase) was measurable during CPB (full heparinization). Spearman’s correlation coefficient (r(s)) was 0.78 for fibrinogen levels and MA CFF (functional fibrinogen). Correlation of several TEG6s parameters was good (0.77 to 0.91) with MCF FIBTEM, and poor (<0.56) with prothrombin time and activated partial thromboplastin time (<0.44). R(s) with platelet count was moderate (0.70, MA CK; 0.73, MA CRT). Accuracy of MA CFF for detection of fibrinogen deficiency < 1.5 g/L was high (ROC-AUC 0.93). CONCLUSIONS: The TEG6s system, which is based on resonance viscoelastic methodology, appears to be feasible for POC hemostasis assessment in cardiac surgery. Its correlations with standard coagulation parameters are quite similar to those of ROTEM and there is good diagnostic accuracy for fibrinogen levels lower than 1.5 g/L. During full heparinization, TEG6s testing is limited to R measurement. Larger studies are needed to assess superiority over other POC systems. Public Library of Science 2018-12-20 /pmc/articles/PMC6301661/ /pubmed/30571781 http://dx.doi.org/10.1371/journal.pone.0209360 Text en © 2018 Erdoes et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Erdoes, Gabor
Schloer, Hannes
Eberle, Balthasar
Nagler, Michael
Next generation viscoelasticity assays in cardiothoracic surgery: Feasibility of the TEG6s system
title Next generation viscoelasticity assays in cardiothoracic surgery: Feasibility of the TEG6s system
title_full Next generation viscoelasticity assays in cardiothoracic surgery: Feasibility of the TEG6s system
title_fullStr Next generation viscoelasticity assays in cardiothoracic surgery: Feasibility of the TEG6s system
title_full_unstemmed Next generation viscoelasticity assays in cardiothoracic surgery: Feasibility of the TEG6s system
title_short Next generation viscoelasticity assays in cardiothoracic surgery: Feasibility of the TEG6s system
title_sort next generation viscoelasticity assays in cardiothoracic surgery: feasibility of the teg6s system
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301661/
https://www.ncbi.nlm.nih.gov/pubmed/30571781
http://dx.doi.org/10.1371/journal.pone.0209360
work_keys_str_mv AT erdoesgabor nextgenerationviscoelasticityassaysincardiothoracicsurgeryfeasibilityoftheteg6ssystem
AT schloerhannes nextgenerationviscoelasticityassaysincardiothoracicsurgeryfeasibilityoftheteg6ssystem
AT eberlebalthasar nextgenerationviscoelasticityassaysincardiothoracicsurgeryfeasibilityoftheteg6ssystem
AT naglermichael nextgenerationviscoelasticityassaysincardiothoracicsurgeryfeasibilityoftheteg6ssystem